HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Parnetti Selected Research

N-Methyl-D-Aspartate Receptors (NMDA Receptors)

10/2007Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Parnetti Research Topics

Disease

19Alzheimer Disease (Alzheimer's Disease)
01/2020 - 02/2000
9Dementia (Dementias)
01/2020 - 03/2000
7Cognitive Dysfunction
01/2020 - 11/2001
7Stroke (Strokes)
04/2006 - 11/2001
3Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
12/2001 - 02/2000
2Parkinson Disease (Parkinson's Disease)
06/2009 - 01/2007
2Hyperhomocysteinemia
01/2007 - 04/2004
2Ischemic Stroke
06/2005 - 01/2000
1Neurocognitive Disorders (Clerambault Syndrome)
01/2020
1Parkinsonian Disorders (Parkinsonism)
01/2020
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2020
1Amyloid Plaque
02/2012
1Synucleinopathies
06/2009
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
11/2008
1CADASIL
11/2008
1Ischemia
10/2007
1Seizures (Absence Seizure)
10/2007
1Embolic Stroke
04/2006
1Hyperlipidemias (Hyperlipidemia)
06/2005
1Transient Ischemic Attack
06/2005
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2005
1Takayasu Arteritis (Arteritis, Takayasu's)
01/2002
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2002
1Vascular Diseases (Vascular Disease)
01/2002
1Blood Vessel Dissection
01/2002
1Autoimmune Diseases (Autoimmune Disease)
01/2002
1Neurobehavioral Manifestations
11/2001
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2001
1Drug-Related Side Effects and Adverse Reactions
06/2000

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2001
4AcetylcholinesteraseIBA
08/2011 - 11/2001
3Amyloid (Amyloid Fibrils)IBA
01/2020 - 10/2003
3ButyrylcholinesteraseIBA
08/2011 - 09/2002
3amyloid beta-protein (1-42)IBA
11/2008 - 02/2001
3HomocysteineIBA
01/2007 - 11/2001
3Cholinergic Agents (Cholinergics)IBA
12/2001 - 11/2001
2EnzymesIBA
06/2009 - 11/2008
2tau Proteins (tau Protein)IBA
11/2008 - 09/2002
2Neuroprotective AgentsIBA
10/2007 - 01/2000
2AnticoagulantsIBA
04/2006 - 06/2005
2Amyloid beta-PeptidesIBA
11/2001 - 01/2001
2Choline (Choline Chloride)IBA
11/2001 - 11/2001
2Glycerylphosphorylcholine (Choline Alfoscerate)IBA
11/2001 - 11/2001
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2020
1Glucosylceramidase (Glucocerebrosidase)IBA
06/2009
1beta-MannosidaseIBA
06/2009
1beta-N-AcetylhexosaminidasesIBA
06/2009
1beta-Galactosidase (Lactaid)IBA
06/2009
1alpha-Mannosidase (LAMAN)IBA
06/2009
13-nitropropionic acidIBA
10/2007
1Levetiracetam (Keppra)FDA LinkGeneric
10/2007
1Glucose (Dextrose)FDA LinkGeneric
10/2007
1MagnesiumIBA
10/2007
1Memantine (Namenda)FDA Link
10/2007
1Oxygen (Dioxygen)IBA
10/2007
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2007
1N-Methylaspartate (NMDA)IBA
10/2007
1Levodopa (L Dopa)FDA LinkGeneric
01/2007
1VitaminsIBA
01/2007
1Cytidine Triphosphate (CTP)IBA
04/2006
1Fibrinolytic Agents (Antithrombotic Agents)IBA
06/2005
1Antiphospholipid AntibodiesIBA
01/2002
1CollagenIBA
01/2002
1Cholinergic ReceptorsIBA
12/2001
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2001
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
11/2001
1PhosphatidylserinesIBA
11/2001
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2001
1Pharmaceutical PreparationsIBA
11/2001
1Cytidine Diphosphate Choline (Citicoline)IBA
11/2001
1Complement System Proteins (Complement)IBA
11/2001
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
11/2001
1LecithinsIBA
11/2001
1Dihydroergocryptine (Dihydroergocryptine Mesylate)FDA Link
06/2000
1Lactic Acid (Lactate)FDA LinkGeneric
02/2000
1Pyruvic Acid (Pyruvate)IBA
02/2000

Therapy/Procedure

2Institutionalization (Institutionalized Persons)
01/2017 - 03/2000
1Stroke Rehabilitation
04/2006
1Secondary Prevention
04/2006
1Therapeutics
06/2005